Keinoshin Wada
Research Subjects
Keinoshin Wada has a total of 9 co-authors. Here are the top co-authors by number of shared publications:
- Noriyoshi Mizuno
Department of Periodontal Medicine Graduate School of Biomedical and Health Sciences Hiroshima University Hiroshima Japan
2 shared publications - Takayoshi Nagahara
Department of Dentistry Nippon Kokan Fukuyama Hospital Fukuyama Japan
2 shared publications - Tomoyuki Iwata
Department of Periodontal Medicine Graduate School of Biomedical and Health Sciences Hiroshima University Hiroshima Japan
2 shared publications - Kazuhisa Ouhara
Department of Periodontal Medicine Graduate School of Biomedical and Health Sciences Hiroshima University Hiroshima Japan
1 shared publication - Kosuke Yamamoto
Yamamoto Dental Clinic Onomichi Japan
1 shared publication - Masaru Shimizu
Department of Periodontal Medicine Graduate School of Biomedical and Health Sciences Hiroshima University Hiroshima Japan
1 shared publication
Latest Publications
- 19 February 2026
- Published by Wiley in Clinical Advances in Periodontics
- Vol. 16 (3) , 618-628
EPPT–CTG regeneration using rhFGF‐2/CO 3 Ap for Cemental Tear Defects: A case report
Background: Cemental tear, representing separation of cementum from the root surface, is a rare but challenging condition often mimicking vertical root fracture or endodontic–periodontal lesions. Despite advances in regenerative therapy, a predictable treatment protocol for cemental tears with non‐contained bone defects remains lacking. Minimally invasive regenerative surgical techniques, such as the entire papilla preservation technique (EPPT) and connective tissue graft (CTG) wall technique, may optimize wound stability and enhance clinical outcomes when combined with biologic agents. Methods: A 73‐year‐old male patient presenting with gingival swelling and suppuration in #8 was diagnosed with a two‐wall bone defect associated with a cemental tear (Class 3/Stage B) using cone‐beam computed tomography (CBCT). Regenerative therapy was performed using recombinant human fibroblast growth factor‐2 (rhFGF‐2), carbonate apatite (CO 3 Ap), and a CTG applied via the EPPT. Clinical parameters and radiographic findings were evaluated at baseline and 1, 3, 6, and 12 months postoperatively. Results: Healing progressed without postoperative complications such as gingival recession or graft exposure. The probing pocket depth was reduced from 10 to ≤3 mm, and clinical attachment gain of 7 mm was achieved at 12 months. CBCT demonstrated complete radiographic bone fill and reformation of the proximal and labial bone walls. Conclusion: Combination regenerative therapy using rhFGF‐2, CO 3 Ap, and CTG with the EPPT achieved stable soft and hard tissue regeneration in an elderly patient with a cemental tear–associated two‐wall bone defect. This multidisciplinary, minimally invasive approach shows promise for managing complex non‐contained intrabony defects while maintaining gingival aesthetics. Key points: A multidisciplinary regenerative approach combining rhFGF‐2, CO 3 Ap, and CTG with EPPT resulted in favorable clinical and radiographic outcomes for a cemental tear–associated two‐wall bone defect. The CTG wall technique functioned as a protective barrier, minimized gingival recession, and promoted soft tissue stability. Cone‐beam computed tomography aided in the accurate diagnosis of cemental tear morphology and postoperative evaluation of bone regeneration. This case underscores the importance of flap design and biologic integration in achieving optimal periodontal and aesthetic results. Plain Language Summary: This case report describes a new treatment method for repairing bone loss around a tooth caused by a “cemental tear,” a type of root surface damage that can lead to gum swelling and bone destruction. A 73‐year‐old male patient was treated with a combination of a growth factor (rhFGF‐2), a synthetic bone substitute (CO 3 Ap), and a small piece of gum tissue (CTG) using a minimally invasive surgical technique that preserves the entire gum papilla. Over 12 months, the treatment resulted in significant healing of both bone and gum tissues without recession. This approach may offer a reliable option for saving teeth with similar severe bone defects.
- 19 February 2026
- Published by Wiley in Clinical Advances in Periodontics
- Vol. 16 (3) , 618-628
EPPT–CTG regeneration using rhFGF‐2/CO 3 Ap for Cemental Tear Defects: A case report
Background: Cemental tear, representing separation of cementum from the root surface, is a rare but challenging condition often mimicking vertical root fracture or endodontic–periodontal lesions. Despite advances in regenerative therapy, a predictable treatment protocol for cemental tears with non‐contained bone defects remains lacking. Minimally invasive regenerative surgical techniques, such as the entire papilla preservation technique (EPPT) and connective tissue graft (CTG) wall technique, may optimize wound stability and enhance clinical outcomes when combined with biologic agents. Methods: A 73‐year‐old male patient presenting with gingival swelling and suppuration in #8 was diagnosed with a two‐wall bone defect associated with a cemental tear (Class 3/Stage B) using cone‐beam computed tomography (CBCT). Regenerative therapy was performed using recombinant human fibroblast growth factor‐2 (rhFGF‐2), carbonate apatite (CO 3 Ap), and a CTG applied via the EPPT. Clinical parameters and radiographic findings were evaluated at baseline and 1, 3, 6, and 12 months postoperatively. Results: Healing progressed without postoperative complications such as gingival recession or graft exposure. The probing pocket depth was reduced from 10 to ≤3 mm, and clinical attachment gain of 7 mm was achieved at 12 months. CBCT demonstrated complete radiographic bone fill and reformation of the proximal and labial bone walls. Conclusion: Combination regenerative therapy using rhFGF‐2, CO 3 Ap, and CTG with the EPPT achieved stable soft and hard tissue regeneration in an elderly patient with a cemental tear–associated two‐wall bone defect. This multidisciplinary, minimally invasive approach shows promise for managing complex non‐contained intrabony defects while maintaining gingival aesthetics. Key points: A multidisciplinary regenerative approach combining rhFGF‐2, CO 3 Ap, and CTG with EPPT resulted in favorable clinical and radiographic outcomes for a cemental tear–associated two‐wall bone defect. The CTG wall technique functioned as a protective barrier, minimized gingival recession, and promoted soft tissue stability. Cone‐beam computed tomography aided in the accurate diagnosis of cemental tear morphology and postoperative evaluation of bone regeneration. This case underscores the importance of flap design and biologic integration in achieving optimal periodontal and aesthetic results. Plain Language Summary: This case report describes a new treatment method for repairing bone loss around a tooth caused by a “cemental tear,” a type of root surface damage that can lead to gum swelling and bone destruction. A 73‐year‐old male patient was treated with a combination of a growth factor (rhFGF‐2), a synthetic bone substitute (CO 3 Ap), and a small piece of gum tissue (CTG) using a minimally invasive surgical technique that preserves the entire gum papilla. Over 12 months, the treatment resulted in significant healing of both bone and gum tissues without recession. This approach may offer a reliable option for saving teeth with similar severe bone defects.
- 23 December 2024
- Published by Wiley in Clinical Advances in Periodontics
- Vol. 16 (1) , 48-55
Saving a hopeless tooth with a four‐wall bone defect: A case report
Background: Recombinant human fibroblast growth factor‐2 (rhFGF‐2) has been shown to effectively promote the formation of new periodontal tissues, and its efficacy has been demonstrated in clinical settings. Moreover, the clinical and radiographic outcomes in the treatment of periodontal infrabony defects can be improved by using rhFGF‐2 in combination with a bone substitute. Here, we present a case of four‐wall bone defect in a tooth treated by combination regenerative therapy using rhFGF‐2 and beta‐tricalcium phosphate (βo‐TCP). Methods: A 43‐year‐old male with a four‐wall bone defect in tooth #28 was subjected to combination therapy with rhFGF‐2 and β‐TCP. Periodontal clinical parameters and radiographic images were evaluated at the first visit, after the initial periodontal treatment, and after 4 months and 4 years postoperation. Results: Although gingival recession and nonvital pulp were observed postoperation, improvements in the periodontal parameters and radiographic outcomes were subsequently recorded. Conclusion: Periodontal regenerative therapy with a combination of rhFGF‐2 and β‐TCP showed great potential in the treatment of four‐wall bone defects of teeth. Key points: Periodontal regenerative therapy using recombinant human fibroblast growth factor‐2 (rhFGF‐2) and beta‐tricalcium phosphate (β‐TCP) showed immense potential in the treatment of four‐wall bone defect in teeth. In addition to using computed tomography for assessing bone defects and root morphologies, an evaluation of root canal morphology and pulp diagnosis is essential for understanding the internal and external aspects of the defect, which would aid in tooth preservation. Appropriate periodontal and endodontic treatments enabled tooth preservation following apical periodontitis after periodontal regenerative therapy. Plain language summary: This case report focuses on a new approach for the treatment of a four‐wall bone defect, a significant dental issue in which the bone around the tooth is damaged, thereby decreasing the stability of the tooth. We treated a 43‐year‐old male patient with a combination of two key components: the growth factor rhFGF‐2, which helps promote the growth of new tissues, and the synthetic bone graft substitute β‐TCP, which acts as a substitute for the missing bone. Over the course of 4 years, we monitored the patient's progress using dental exams and X‐ray photos. Despite some minor side effects, such as gum recession and the loss of tooth vitality, the overall condition of the tooth and surrounding bone showed significant improvement. This combination therapy shows promise in repairing similar bone defects, which would help save teeth that might otherwise be lost.
- 23 December 2024
- Published by Wiley in Clinical Advances in Periodontics
- Vol. 16 (1) , 48-55
Saving a hopeless tooth with a four‐wall bone defect: A case report
Background: Recombinant human fibroblast growth factor‐2 (rhFGF‐2) has been shown to effectively promote the formation of new periodontal tissues, and its efficacy has been demonstrated in clinical settings. Moreover, the clinical and radiographic outcomes in the treatment of periodontal infrabony defects can be improved by using rhFGF‐2 in combination with a bone substitute. Here, we present a case of four‐wall bone defect in a tooth treated by combination regenerative therapy using rhFGF‐2 and beta‐tricalcium phosphate (βo‐TCP). Methods: A 43‐year‐old male with a four‐wall bone defect in tooth #28 was subjected to combination therapy with rhFGF‐2 and β‐TCP. Periodontal clinical parameters and radiographic images were evaluated at the first visit, after the initial periodontal treatment, and after 4 months and 4 years postoperation. Results: Although gingival recession and nonvital pulp were observed postoperation, improvements in the periodontal parameters and radiographic outcomes were subsequently recorded. Conclusion: Periodontal regenerative therapy with a combination of rhFGF‐2 and β‐TCP showed great potential in the treatment of four‐wall bone defects of teeth. Key points: Periodontal regenerative therapy using recombinant human fibroblast growth factor‐2 (rhFGF‐2) and beta‐tricalcium phosphate (β‐TCP) showed immense potential in the treatment of four‐wall bone defect in teeth. In addition to using computed tomography for assessing bone defects and root morphologies, an evaluation of root canal morphology and pulp diagnosis is essential for understanding the internal and external aspects of the defect, which would aid in tooth preservation. Appropriate periodontal and endodontic treatments enabled tooth preservation following apical periodontitis after periodontal regenerative therapy. Plain language summary: This case report focuses on a new approach for the treatment of a four‐wall bone defect, a significant dental issue in which the bone around the tooth is damaged, thereby decreasing the stability of the tooth. We treated a 43‐year‐old male patient with a combination of two key components: the growth factor rhFGF‐2, which helps promote the growth of new tissues, and the synthetic bone graft substitute β‐TCP, which acts as a substitute for the missing bone. Over the course of 4 years, we monitored the patient's progress using dental exams and X‐ray photos. Despite some minor side effects, such as gum recession and the loss of tooth vitality, the overall condition of the tooth and surrounding bone showed significant improvement. This combination therapy shows promise in repairing similar bone defects, which would help save teeth that might otherwise be lost.